Paul J. Kostenuik
0000-0001-7209-1368
Publication & Citation Trends
Publications
0 total
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone
Cited by 12
Semantic Scholar
Abaloparatide Increases Bone Mineral Density in Regions Corresponding to Gruen Zones 1, 2, 6, and 7 in Postmenopausal Women With Osteoporosis
Cited by 2
Semantic Scholar
Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth OA
Cited by 1
Semantic Scholar
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health OA
Cited by 29
Semantic Scholar
Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys OA
Cited by 5
Semantic Scholar
Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys.
Cited by 1
Semantic Scholar
On the evolution and contemporary roles of bone remodeling
Cited by 7
Semantic Scholar
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects OA
Cited by 39
Semantic Scholar
Pharmacological mechanisms of therapeutics
Cited by 0
Semantic Scholar
List of Contributors
Cited by 0
Semantic Scholar
Research Topics
Bone Metabolism and Diseases
(103)
Bone health and treatments
(98)
Bone health and osteoporosis research
(56)
NF-κB Signaling Pathways
(12)
Orthopaedic implants and arthroplasty
(11)
Affiliations
Boston University
San Francisco VA Medical Center
Amgen (United States)
Harvard University
University of California, San Francisco